Table 2 Antibiotic consumption in the septic ward during quarters 1/2013 to 2/2016
Antibiotic consumption (DDD/100 hospital bed days) | p a | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2013 | 2014 | 2015 | 2016 | ||||||||||||
Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | ||
Narrow spectrum penicillinsb | 8.8 | 20.8 | 16.5 | 26.3 | 6.8 | 11.3 | 8.3 | 15.0 | 26.5 | 19.6 | 13.0 | 34.8 | 35.0 | 52.0 | 0.131 |
Amino penicillin/BLI | 7.8 | 3.2 | 0.5 | 1.8 | 6.4 | 4.1 | 15.4 | 4.3 | 7.2 | 10.9 | 16.7 | 16.3 | 10.0 | 7.2 | 0.044 |
Broad spectrum penicillinsc | 2.7 | 1.0 | 1.6 | 0.0 | 2.4 | 3.4 | 5.2 | 2.0 | 4.5 | 2.3 | 8.2 | 4.5 | 3.5 | 5.1 | 0.046 |
Cephalosprins 1st and 2nd gen. | 12.2 | 27.2 | 42.3 | 32.3 | 35.5 | 43.3 | 23.0 | 30.5 | 21.5 | 32.8 | 22.2 | 23.0 | 14.0 | 23.5 | 0.016 |
Cephalosprins 3rd gen. | 2.1 | 3.2 | 2.1 | 2.4 | 4.1 | 3.7 | 0.8 | 1.5 | 0.9 | 0.6 | 1.7 | 0.0 | 1.8 | 0.0 | 0.015 |
Carbapenems | 4.8 | 3.2 | 5.1 | 2.7 | 7.9 | 3.0 | 4.9 | 5.9 | 3.4 | 5.0 | 5.1 | 10.0 | 2.4 | 6.8 | 0.283 |
Fluoroquinolones | 49.7 | 35.0 | 29.7 | 21.6 | 32.6 | 45.1 | 34.3 | 32.0 | 33.6 | 31.2 | 26.0 | 6.6 | 4.3 | 10.6 | 0.006 |
Clindamycin | 9.1 | 12.1 | 19.3 | 0.0 | 12.3 | 25.2 | 19.4 | 12.6 | 22.1 | 15.2 | 6.8 | 3.7 | 4.4 | 5.1 | 0.001 |
Linezolid | 2.4 | 3.2 | 4.4 | 2.4 | 4.0 | 3.6 | 3.5 | 2.0 | 2.8 | 7.9 | 4.8 | 6.9 | 8.7 | 10.1 | 0.019 |
Glycopeptide/daptomycin | 5.4 | 5.9 | 5.7 | 1.5 | 6.2 | 4.5 | 4.6 | 3.8 | 5.1 | 3.6 | 4.8 | 8.9 | 5.4 | 13.8 | 0.143 |
Rifampicin | 18.3 | 14.1 | 19.2 | 0.4 | 9.7 | 9.9 | 0.0 | 0.0 | 3.5 | 10.1 | 4.5 | 17.8 | 12.2 | 13.9 | 0.243 |
Total | 125.6 | 132.3 | 150.6 | 106.9 | 129.7 | 157.3 | 122.7 | 113.1 | 133.0 | 141.6 | 122.1 | 133.5 | 103.5 | 150.2 | 0.348 |